Soleus Capital Management, L.P. 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Soleus Capital Management, L.P. disclosed 74 US equity positions worth $1.3bn in its Q1 2025 13F filing. The largest position was TGTX at 8.8% of the reported book, followed by NVCR and KRYS. Against the Q4 2024 filing, it opened 11 new positions, added to 18 and reduced 10 among the top 50 holdings.
What did Soleus Capital Management, L.P. own in Q1 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | TGTX TG THERAPEUTICS INC | Healthcare | 8.8% | $112.2m | 2,846,703 | 6% | added |
| 2 | NVCR NOVOCURE LTD | Healthcare | 7.7% | $98.4m | 5,521,414 | 102% | added |
| 3 | KRYS KRYSTAL BIOTECH INC | Healthcare | 6.2% | $79.6m | 441,758 | 23% | added |
| 4 | BMRN BIOMARIN PHARMACEUTICAL INC | Healthcare | 6.0% | $76.3m | 1,079,304 | 8% | added |
| 5 | ORGO ORGANOGENESIS HLDGS INC | Healthcare | 4.2% | $53.9m | 12,478,351 | -0% | held |
| 6 | GRFS GRIFOLS S A | Healthcare | 4.0% | $50.4m | 7,089,822 | 7% | added |
| 7 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 3.8% | $47.9m | 155,394 | 42% | added |
| 8 | STAA STAAR SURGICAL CO | Healthcare | 3.5% | $45.2m | 2,562,893 | – | new |
| 9 | PRAX PRAXIS PRECISION MEDICINES I | Healthcare | 3.4% | $43.2m | 1,139,740 | 368% | added |
| 10 | BBNX BETA BIONICS INC | Healthcare | 3.3% | $41.6m | 3,395,341 | – | new |
| 11 | NPCE NEUROPACE INC | 2.5% | $32.1m | 2,608,168 | 7% | added | |
| 12 | NRIX NURIX THERAPEUTICS INC | Healthcare | 2.3% | $28.8m | 2,422,833 | 15% | added |
| 13 | AXGN AXOGEN INC | Healthcare | 2.1% | $26.8m | 1,446,117 | -51% | reduced |
| 14 | CELC CELCUITY INC | Healthcare | 2.0% | $26.0m | 2,574,122 | 0% | held |
| 15 | IOVA IOVANCE BIOTHERAPEUTICS INC | Healthcare | 2.0% | $25.9m | 7,785,000 | 19% | added |
| 16 | SU6 SURMODICS INC | 1.9% | $24.1m | 789,060 | 100% | added | |
| 17 | IART INTEGRA LIFESCIENCES HLDGS C | Healthcare | 1.8% | $23.6m | 1,072,204 | -16% | reduced |
| 18 | 430 TERNS PHARMACEUTICALS INC | 1.8% | $22.5m | 8,167,100 | 0% | held | |
| 19 | MDGL MADRIGAL PHARMACEUTICALS INC | Healthcare | 1.8% | $22.4m | 67,500 | 519% | added |
| 20 | INSM INSMED INC | Healthcare | 1.6% | $20.9m | 274,272 | -14% | reduced |
| 21 | RIGL RIGEL PHARMACEUTICALS INC | 1.6% | $20.3m | 1,130,679 | 0% | held | |
| 22 | HO1 HOLOGIC INC | 1.5% | $18.7m | 302,000 | – | new | |
| 23 | ARGX ARGENX SE | Healthcare | 1.3% | $17.1m | 28,940 | – | new |
| 24 | MERUS N V | 1.3% | $16.2m | 385,821 | 24% | added | |
| 25 | NUVALENT INC | 1.2% | $15.2m | 214,357 | 105% | added | |
| 26 | ANIP ANI PHARMACEUTICALS INC | Healthcare | 1.2% | $15.0m | 224,684 | 9% | added |
| 27 | EDAP TMS S A | 1.1% | $14.3m | 7,309,254 | 0% | held | |
| 28 | IKT INHIBIKASE THERAPEUTICS INC | 1.1% | $13.9m | 6,325,000 | 0% | held | |
| 29 | EOLS EVOLUS INC | Healthcare | 1.0% | $13.0m | 1,079,158 | 55% | added |
| 30 | PHVS PHARVARIS N V | 1.0% | $12.8m | 814,652 | 0% | held | |
| 31 | SNY SANOFI | 1.0% | $12.5m | 226,218 | – | new | |
| 32 | CCCC C4 THERAPEUTICS INC | Healthcare | 0.9% | $11.2m | 6,978,942 | 0% | held |
| 33 | SLNOEUR SOLENO THERAPEUTICS INC | 0.8% | $10.7m | 150,000 | – | new | |
| 34 | KINIKSA PHARMACEUTICALS INTL | 0.8% | $10.4m | 469,500 | – | new | |
| 35 | ACLXGBX ARCELLX INC | 0.8% | $10.0m | 153,031 | 26% | added | |
| 36 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.8% | $10.0m | 816,610 | -67% | reduced |
| 37 | OFIX ORTHOFIX MED INC | Healthcare | 0.8% | $9.8m | 601,925 | -12% | reduced |
| 38 | TNDM TANDEM DIABETES CARE INC | Healthcare | 0.7% | $9.5m | 496,039 | – | new |
| 39 | SRRK SCHOLAR ROCK HLDG CORP | Healthcare | 0.7% | $9.2m | 285,000 | 70% | added |
| 40 | ASND ASCENDIS PHARMA A/S | Healthcare | 0.7% | $8.8m | 56,300 | -61% | reduced |
| 41 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 0.6% | $8.2m | 169,000 | -39% | reduced |
| 42 | IMUX IMMUNIC INC | Healthcare | 0.6% | $7.9m | 7,293,007 | 0% | held |
| 43 | CGON CG ONCOLOGY INC | Healthcare | 0.6% | $7.4m | 303,585 | -8% | reduced |
| 44 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.5% | $6.9m | 450,500 | -78% | reduced |
| 45 | THERATECHNOLOGIES INC | 0.5% | $6.7m | 4,801,376 | 0% | held | |
| 46 | JSPR JASPER THERAPEUTICS INC | 0.5% | $6.4m | 1,494,420 | 0% | held | |
| 47 | INSP INSPIRE MED SYS INC | Healthcare | 0.5% | $6.2m | 39,000 | – | new |
| 48 | VSTM VERASTEM INC | Healthcare | 0.4% | $5.6m | 935,909 | -57% | reduced |
| 49 | AKERO THERAPEUTICS INC | 0.4% | $4.7m | 117,000 | – | new | |
| 50 | LIVN LIVANOVA PLC | Healthcare | 0.4% | $4.6m | 117,040 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.